Activation of Endothelial and Coagulation Systems in Left Ventricular Assist Device Recipients

Ranjit John(University of Minnesota), Robert P. Hebbel(University of Minnesota), Peng Wei(Creighton University), Sandhya R. Panch(University of Washington), Jennifer E. Hrabe(University of Iowa Hospitals and Clinics), Anna Solovey(University of Minnesota), Lyle D. Joyce(Medical College of Wisconsin)
The Annals of Thoracic Surgery
September 19, 2009
10.1016/j.athoracsur.2009.06.095
Cited by 116

Related Papers

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
|The Lancet|2015|518
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422